Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression
Non-small-cell lung cancer (NSCLC) is one of the most devastating diseases worldwide. The study is aimed at identifying reliable prognostic biomarkers and to improve understanding of cancer initiation and progression mechanisms. RNA-Seq data were downloaded from The Cancer Genome Atlas (TCGA) databa...
Main Authors: | Jia-Jia Zhang, Jiang Hong, Yu-Shui Ma, Yi Shi, Dan-Dan Zhang, Xiao-Li Yang, Cheng-You Jia, Yu-Zhen Yin, Geng-Xi Jiang, Da Fu, Fei Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2021/6696198 |
Similar Items
-
NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma
by: Yan Tang, et al.
Published: (2021-01-01) -
The effects of NMU in the immunobiology of Xenopus laevis
by: James, H. S.
Published: (1983) -
Neuromedins NMU and NMS: An Updated Overview of Their Functions
by: Ludwik K. Malendowicz, et al.
Published: (2021-07-01) -
Bioinformatics Analysis Identifying Key Biomarkers in Bladder Cancer
by: Chuan Zhang, et al.
Published: (2020-04-01) -
Histological analysis of low dose NMU effects in the rat mammary gland
by: Sonnenschein Carlos, et al.
Published: (2009-08-01)